|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Textbook Outcome as a measure of surgical quality assessment and prognosis in gastric neuroendocrine carcinoma:A large multicenter sample analysis显示文摘Objective:Quality assurance is crucial for oncological surgical treatment assessment.For rare diseases,singlequality indicators are not enough.We aim to develop a comprehensive and reproducible measurement,called the'Textbook Outcome'(TO),to assess the quality of surgical treatment and prognosis of gastric neuroendocrine carcinoma(G-NEC)patients.Methods:Data from patients with primary diagnosed G-NEC included in 24 high-volume Chinese hospitals from October 2005 to September 2018 were analyzed.TO included receiving a curative resection,≥15 lymph nodes examined,no severe postoperative complications,hospital stay≤21 d,and no hospital readmission≤30 d after discharge.Hospital variation in TO was analyzed using a case mix-adjusted funnel plot.Prognostic factors of survival and risk factors for non-Textbook Outcome(non-TO)were analyzed using Cox and logistic models,respectively.Results:TO was achieved in 56.6%of 860 G-NEC patients.TO patients had better overall survival(OS),disease-free survival(DFS),and recurrence-free survival(RFS)than non-TO patients(P<0.05).Moreover,TO patients accounted for 60.3%of patients without recurrence.Multivariate Cox analysis revealed non-TO as an independent risk factor for OS,DFS,and RFS of G-NEC patients(P<0.05).Increasing TO rates were associated with improved OS for G-NEC patients,but not hospital volume.Multivariate logistic regression revealed that nonlower tumors,open surgery,and>200 mL blood loss were independent risk factors for non-TO patients(P<0.05).Conclusions:TO is strongly associated with multicenter surgical quality and prognosis for G-NEC patients.Factors predicting non-TO are identified,which may help guide strategies to optimize G-NEC outcomes. | Qiyue Chen Zhongliang Ning Zhiyu Liu Yanbing Zhou Qingliang He Yantao Tian Hankun Hao Wei Lin Lixin Jiang Gang Zhao Ping Li Chaohui Zheng Changming Huang on behalf of the Study Group for Gastric Neuroendocrine Tumors | 2021 | Chinese Journal of Cancer Research2021，33，4： | 2 |
| 2 | 胃癌的手术治疗(附1,487例分析)显示文摘从我省胃癌协作组12个协作单位在1978至1984年底收治的1,487例胃癌病例治疗情况来看——手术率为84.2%,切除手术率为54.4%,切除手术患者的3和5年生存率分别为28.7%及18.9%,虽取得了较大成绩,疗效还不令人满意。根据本组协作单位临床经验,患者的年龄、病期、肿瘤大小、组织学类型、胃癌浆膜侵犯程度、淋巴结转移情况、肿瘤部位、手术方式、联合脏器切除情况等,都是影响胃癌疗效的因素。提高胃癌疗效的关键是早期诊断和早期治疗,因而,须努力提高胃瘤的早期确诊率。此外,合理的外科治疗对提高胃癌疗效亦非常重要。我们认为应大力推广清除第二站淋巴结根治术;适当开展扩大根治术及联合脏器切除术式;而对不能作根治手术的患者也要争取作姑息性切除,使其延长生存期。 | Tan Chun-Qi Co-operative Group for Gastric Cancer of Hunan Province,Changsha | 1989 | 中国肿瘤临床1989，16，1： | 2 |
| 3 | Benefit of adju- vant chemotherapy for resectable gastric cancer: a meta- analysis显示文摘 | GASTRIC Group Paoletti X Oba K | 2010 | JAMA2010，303，7： | 1 |
| 4 | Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial显示文摘 | Wong BC Lam SK Wong WM China Gastric Cancer Study Group | 2004 | JAMA2004，291，2： | 1 |
| 5 | Role of chemotherapy for advanced/recurrent gastric cancer:an individual-patient-data meta-analysis显示文摘 | GASTRIC Group Oba K Paoletti X | | 0，，： | 1 |
| 6 | Benefit of adju- vant chemotherapy for resectable gastric canc- er= a meta-analysis显示文摘 | GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration ) Group Paoletti X Oba K | 2010 | JAMA2010，303，17： | 1 |
| 7 | Benefit of Adjuvant Chemotherapy for Resectable Gastric cancer显示文摘 | The GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International collaboration) Group | 2010 | JAMA2010，303，17： | 1 |
| 8 | Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial显示文摘 | Degiuli M Sasako M Calgaro M Italian Gastric Cancer Study Group | 2004 | Eur J Surg Oncol2004，30，3： | 1 |
| 9 | Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis显示文摘 | GASTRIC (Global Advanced / Adj uvant Stomach Tumor Research International Collaboration) Group PAOLETTI X OBA K | 2010 | JAMA2010，303，17： | 1 |
| 10 | Benefit of adjuvant chemotherapy for the gastric cancer显示文摘 | The Gastric Group | 2010 | JAMA2010，303，17： | 1 |
| 11 | Benefit of adjuvant chemotherapy for reseetable gastric cancer: a recta- analysis显示文摘 | GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group Paoletti X Oba K | 2010 | JAMA2010，303，17： | 1 |
| 12 | Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan 显示文摘 | Hongo M Fujimoto K Gastric Polyps Study Group | 2010 | J Gastroen- terol2010，45，6： | 1 |
| 13 | Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis 显示文摘 | GASTRIC Group Paoletti X Oba K | 2010 | JAMA2010，303，17： | 1 |
| 14 | Bene- fit of adjuvant chemotherapy for resectable gastric cancer: a meta - analysis 显示文摘 | GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration)Group Paoletti X Oba K | 2010 | JAMA2010，303，17： | 1 |
| 15 | Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China:a randomized controlled trial显示文摘 | Wong BC Lain SK Wong WM China Gastric Cancer Study Group | 2004 | lAMA2004，291，2： | 1 |
| 16 | Benefit of adjuvant chemotherapy for resectable gastric cancer a meta-analysis 显示文摘 | GASTRIC Group Paoletti X Oba K | 2010 | JAMA2010，303，17： | 1 |
| 17 | Benefit of adjuvant chemother- apy for resectable gastric cancer: a meta- analysis显示文摘 | GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group | 2010 | JAMA2010，303，17： | 1 |
| 18 | Incidence and risk factor offundic gland polyp and hy perplastic polyp in long-term proton pump inhibitor therapy=a prospective study in Japan显示文摘 | Hongo M Fujimoto K Gastric Polyps Study Group | 2010 | J Gastroen- terol2010，45，6： | 1 |
| 19 | Benefit of adjuvant chemotherapy for resect- able gastric cancer: a recta-analysis 显示文摘 | GASTRIC ( Global Advanced/Adjuvant Stomach Tumor Re- search International Collaboration ) Group Paoletti X Oba K | 2010 | JAMA2010，303，17： | 1 |
| 20 | Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis显示文摘 | GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group PaolettiX ObaK | 2010 | JAMA2010，303，17： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员